|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,398.50 JPY | -0.27% |
|
+0.42% | +10.40% |
| Market Cap | 1,127B 6.88B 6.04B 5.62B 5.17B 9.68B 664B 9.87B 66.59B 26.14B 325B 25.83B 25.27B | P/E 2027 * |
15.9x | P/E 2028 * | 18x |
|---|---|---|---|---|---|
| Enterprise Value | 928B 5.66B 4.98B 4.62B 4.25B 7.97B 547B 8.13B 54.82B 21.52B 268B 21.26B 20.81B | EV / Sales 2027 * |
2.04x | EV / Sales 2028 * | 2.04x |
| Free-Float |
80.98% | Yield 2027 * |
3.27% | Yield 2028 * | 3.23% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | -0.27% | ||
| 1 week | +0.42% | ||
| Current month | +0.44% | ||
| 1 month | +2.26% | ||
| 3 months | +3.32% | ||
| 6 months | +5.94% | ||
| Current year | +10.40% |
| 1 week | 2,354 |  | 2,448.5 |
| 1 month | 2,323 | | 2,507 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,596 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 4,008 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 76 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.27% | +0.42% | +51.66% | -6.22% | 6.93B | |
| +0.57% | +0.13% | +16.45% | +78.10% | 48.31B | |
| -0.50% | -0.41% | +67.13% | +107.90% | 35.33B | |
| -1.56% | -3.13% | -4.88% | +32.80% | 11.85B | |
| -1.11% | -3.73% | +16.41% | +81.64% | 11.64B | |
| -0.37% | -0.19% | +36.48% | +136.73% | 8.99B | |
| -0.77% | -3.00% | +13.55% | +32.01% | 6.72B | |
| +0.24% | -4.02% | +2.19% | +192.78% | 6.43B | |
| +1.60% | -9.55% | -30.77% | +8.47% | 5.66B | |
| -0.55% | -0.41% | +25.54% | +143.67% | 4.48B | |
| Average | -0.27% | -1.55% | +19.38% | +80.79% | 14.64B | |
| Weighted average by Cap. | -0.16% | -0.90% | +27.54% | +83.75% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 454B 2.77B 2.44B 2.26B 2.08B 3.9B 268B 3.98B 26.84B 10.54B 131B 10.41B 10.19B | 444B 2.71B 2.38B 2.22B 2.04B 3.82B 262B 3.89B 26.26B 10.31B 128B 10.19B 9.97B |
| Net income | 70.98B 433M 381M 354M 325M 610M 41.82B 622M 4.19B 1.65B 20.48B 1.63B 1.59B | 62.51B 381M 335M 312M 287M 537M 36.83B 548M 3.69B 1.45B 18.04B 1.43B 1.4B |
| Net Debt | -199B -1.22B -1.07B -993M -913M -1.71B -117B -1.74B -11.77B -4.62B -57.49B -4.56B -4.47B | -218B -1.33B -1.17B -1.09B -1B -1.87B -129B -1.91B -12.89B -5.06B -62.98B -5B -4.89B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | JP¥2,398.50 | -0.27% | 1,081,400 |
| 26-07-22 | JP¥2,405.00 | +0.33% | 1,236,400 |
| 26-07-21 | JP¥2,397.00 | -1.18% | 1,492,300 |
| 26-07-17 | JP¥2,425.50 | +3.37% | 2,057,200 |
| 26-07-16 | JP¥2,346.50 | -1.76% | 1,579,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
